Breast Cancer - Is Clistemab a Second Line Therapy?

It depends on the chemo sensitivity of the disease. In breast cancer, you're seeing a bit longer than that. And also it's longer if you give it upfront in the first or second line setting rather than fourth and fifth line. So I think those numbers can change depending on the clinical context. We're hoping that there's the lungo4, which is the first line trial, will produce superior outcomes. But the jury's still out.